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Abstract
Background: Pelvic Organ Prolapse (POP) is estimated to affect 41%–50% of women aged over 40. Findings from the
multi-centre randomised controlled “Pelvic Organ Prolapse PhysiotherapY” (POPPY) trial showed that individualised
pelvic floor muscle training (PFMT) was effective in reducing symptoms of prolapse, improved quality of life and
showed clear potential to be cost-effective. However, provision of PFMT for prolapse continues to vary across the UK,
with limited numbers of women’s health physiotherapists specialising in its delivery. Implementation of this robust
evidence from the POPPY trial will require attention to different models of delivery (e.g. staff skill mix) to fit with
differing care environments.
Methods: A Realist Evaluation (RE) of implementation and outcomes of PFMT delivery in contrasting NHS settings will
be conducted using multiple case study sites. Involving substantial local stakeholder engagement will permit a detailed
exploration of how local sites make decisions on how to deliver PFMT and how these lead to service change. The RE
will track how implementation is working; identify what influences outcomes; and, guided by the RE-AIM framework,
will collect robust outcomes data. This will require mixed methods data collection and analysis.
Qualitative data will be collected at four time-points across each site to understand local contexts and decisions
regarding options for intervention delivery and to monitor implementation, uptake, adherence and outcomes. Patient
outcome data will be collected at baseline, six months and one year follow-up for 120 women. Primary outcome will
be the Pelvic Organ Prolapse Symptom Score (POP-SS). An economic evaluation will assess the costs and benefits
associated with different delivery models taking account of further health care resource use by the women. Cost data
will be combined with the primary outcome in a cost effectiveness analysis, and the EQ-5D-5L data in a cost utility
analysis for each of the different models of delivery.
Discussion: Study of the implementation of varying models of service delivery of PFMT across contrasting sites
combined with outcomes data and a cost effectiveness analysis will provide insight into the implementation and
value of different models of PFMT service delivery and the cost benefits to the NHS in the longer term.
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Background
Pelvic organ prolapse (POP) is a common condition af-
fecting 41%–50% of women over the age of 40 [1, 2].
POP is defined as the symptomatic descent of one or
more of the anterior or posterior vaginal walls, apex of
the vagina or the uterus (cervix) [3]. A rising number of
POP cases result in surgery (15 to 49 cases per 10,000
women-years) [4–6]. As well as having associated mor-
bidity, surgery is often prone to failure; around 30% of
women undergo repeat operations, and the time intervals
between repeat procedures shorten with each successive
repair [5]. In addition, repair of one type of prolapse may
predispose the woman to the development of a different
type of prolapse in another compartment of the vagina [5].
There remain concerns surrounding the use of synthetic
mesh, one option for prolapse surgery. Mesh-related
complications are frequently reported, with up to a 35%
removal rate [7] resulting in the Chief Medical Officer
in Scotland (UK) requesting that all Health Boards con-
sider suspending routine use of polypropylene mesh
implants for the management of pelvic organ prolapse
and incontinence in June 2014 [8].
Given these concerns, there is an ever more pressing
need for evidence-based non-surgical options to be made
available to women [9]. A recent definitive trial has shown
that pelvic floor muscle training is an effective and poten-
tially cost effective treatment and should be recommended
as a first line treatment for POP [10]. The Pelvic Organ
Prolapse PhysiotherapY (POPPY) trial was a multi-centre
randomised controlled trial of the effectiveness and cost-
effectiveness of individualised pelvic floor muscle training
(PFMT) delivered by specialist physiotherapists compared
to a lifestyle advice leaflet in newly diagnosed women with
symptomatic stage I, II or III prolapse [10]. POPPY consti-
tutes the largest, most rigorous, pragmatic trial of PFMT
for prolapse, and as such provides the necessary evidence
to inform future practice. Individualised PFMT was found
to be effective in reducing women’s symptoms of prolapse,
and providing perceived improvements in prolapse and
related quality of life. The PFMT intervention also shows
potential to be a cost-effective treatment.
However, knowledge of efficacy and effectiveness is not
enough to ensure implementation of this evidence into
practice. PFMT provision varies across the UK as there is
limited availability of specialist physiotherapy services to
meet the known levels of demand [11, 12]. Delivery
methods that can enhance service capacity and increase
availability and choice for women are required. Such deliv-
ery methods also need to be tested to ensure that the out-
comes achieved under trial conditions are maintained.
This study aims to maximise the delivery of effective
PFMT for women with POP through the study of its
implementation in a number of diverse settings using
an evidence-based PFMT protocol. This will involve
developing different service delivery models, incorporating
a variety of staff skill mixes and sessions to increase cap-
acity, with the format of delivery being determined locally.
These will be addressed through the following specific
study aims:
 To explore the potential for different groups of staff
skill mix to deliver PFMT without compromising
the achievement of clinical outcomes
 To explore fidelity or variation to PFMT protocol
(e.g. number and type of sessions) and the impact of
any variations
 To establish the levels of support required by
non-specialist physiotherapists to deliver PFMT
 To explore the acceptability and outcomes for
women of different delivery models
 To establish the costs and benefits associated with
each model of delivery
 To contribute to knowledge of how and why
implementation processes are successful (or not)
through exploring what works, for whom and in
what circumstances.
Implementation Science is an emerging field aiming to
foster understanding of the complex and multi-level
processes involved in the uptake and spread/scale-up of
evidence-based interventions and programmes [13]. It
aims not only to reduce a gap in quality of care, but
also to advance the science of implementation by pro-
viding generalisable knowledge that will be useful for
other settings and contexts. It can help to identify bar-
riers to implementation but should also extend this to
understand how and why implementation processes are
effective [14]. To do this we need to study implementa-
tion strategies and the contexts and processes in which
implementation strategies are delivered. Such research
can advance the adoption, sustainability and wider roll
out of cost-effective evidence based interventions and
are a necessary step in the MRC’s evaluation of com-
plex interventions framework [15].
Methods/design
Study design
The study will involve: A) A Realist Evaluation (RE) using
case studies of implementation of PFMT delivery in three
varying NHS settings; B) An outcomes study of PFMT de-
livery in the different models; C) An economic evaluation
to compare the costs and benefits of the different models.
A) Realist Evaluation using case studies of
implementation
The RE will involve substantial local stakeholder engage-
ment, allowing local sites to make decisions on how to
deliver PFMT (within their resources) and will elicit
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local folk theories around: how implementation is sup-
posed to work; track how the implementation is working
(including fidelity to the PFMT protocol); and under-
stand what influences outcomes.
Setting
The Realist Evaluation will be based at three NHS sites in
the UK with either specialist pelvic floor or women’s health
services, and selecting sites reflecting a mix of urban/rural
locations, previous involvement/non-involvement in
POPPY and current differences in service delivery models
(see Table 1). A lead specialist physiotherapist based at
each location will facilitate liaising with local service
managers/consultants and staff to take part in develop-
ing a local model of PFMT service provision; the re-
search team will consent those participating into the
study.
B) Outcomes study
Outcomes data will be collected before and after women
receive the PFMT intervention in each location/model
of service delivery to establish whether the improvements
observed in the POPPY trial are also observed under
different models of delivery and in non-trial real world
NHS settings (see Table 2).
Recruitment/sampling
Women who are awaiting treatment for prolapse at
study sites will be potential recruits if they are eligible
and provide written, informed consent to take part. We
aim to recruit 120 women to the outcomes study.
Inclusion criteria
 Women 18 years of age or above, presenting with
symptomatic stage I, II or III prolapse of any type
who are suitable to be referred for PFMT and who
are willing to take part in the research and comply
with necessary data collection.
Exclusion criteria
 Women who are pregnant or less than one year
postnatal
 Women who have prolapse greater than stage III,
who have pelvic cancer, cognitive impairment or
neurological disease (as indicated by referral source
or patient/carer reported at assessment consultation)
Sample size
We have assumed that the minimum clinically important
difference in the POP − SS is 2 [16] and that the standard
deviation of the differences in POP − SS between baseline
and one year will be 5.5 (as observed in POPPY). A
sample size of 120 paired observations (with 2-sided
alpha = 0.05) will therefore provide 80% power to detect
important differences in POP − SS between baseline
and one year.
Setting
The outcomes study will be based at five sites, those
three taking part in the RE plus two further sites who
will be recruited to specifically take part in the outcomes
study (see Table 1). Clinicians identified locally at each
site will be trained to deliver the PFMT intervention by
Pelvic, Obstetric and Gynaecological Physiotherapy ap-
proved trainers.
C) Economic evaluation
An economic evaluation will compare costs and out-
comes of the different models of service delivery.
The PFMT intervention
PFMT refers to the regular practice of repetitive pelvic
floor muscle contractions in order to produce a training
effect on the muscles. The aim of a PFMT programme is
to increase the strength of the muscles to build up muscle
volume thereby improving structural support, increase
endurance, improve resting tone, improve muscle fibre
Table 1 Realist Evaluation Study site descriptions
Site Urban/rural POPPY experience Current dominant model
1 Urban POPPY recruiting centre Primary and secondary care provision of specialist physiotherapy
referred by primary care and acute services with a mix of 1:1 and
group provision available. Women not routinely sent to physiotherapy
as first line treatment. Several POPPY physiotherapists providing
current input to women with POP
2 Urban Large involvement in medically
driven trials but no focus on
physiotherapy based trials
Currently has some specialist physiotherapy involvement but
greater specialist nurse-led service for women
No POPPY involvement
3 Rural No POPPY involvement and limited
other trial involvement
Current interest in re-design and expanding to junior grade
physiotherapists and other nursing staff (as practitioners with
special interest)
POP Pelvic Organ Prolapse, POPPY Pelvic Organ Prolapse PhysiotherapY trial
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recruitment through improved nerve function and proper-
ties of muscle fibres; and improve cognitive awareness of
body posture and a relaxed versus an un-relaxed state of
the pelvic floor [17]. To produce improvements in muscle
strength and endurance the basic physiological principles
must be adhered to [18]. These include: overload (muscles
need to perform more work than usual resulting in fa-
tigue); specificity (muscles must be trained with physical
activity that replicates as closely as possible the functional
movement required); maintenance and reversibility
(benefits of the exercise are reversible if they are not
undertaken on a regular basis). Evidence suggests that
for effective strength training in skeletal muscles in
adults, three to five sets of 8 to 12 slow velocity, close
to maximal contractions per day should be performed 2
to 5 days per week for 16 weeks [19].
The PFMT protocol will normally be delivered during
five therapy appointments at weeks 0, 2, 6, 11, 16 with
fewer or more appointments as judged by therapists
based on client needs. The intervention will normally
last 16 weeks. Each of the five appointments will take
around 30 min each, with the initial appointment ex-
pected to take longer (45–60 min). The initial assessment
appointment will elicit and record basic demographic and
medical history along with a visual and digital assessment
of the vagina and pelvic floor muscles. The initial assess-
ment aims to provide accurate knowledge of the condition
of the perineum and vagina, the woman’s capacity for
contracting and relaxing her pelvic floor muscles and
the influence of muscles on any visible or palpable pro-
lapse. This information is recorded using the Oxford
Classification (PERFECT scheme) and provides a basis
for determining the dose/frequency of PFMT [20].
Women are taught the correct exercise technique and
this is confirmed on digital palpation by the therapist
with the woman in the supine position. Women are
encouraged to become aware of contracting and holding
the muscles, and also of relaxing them. This is facilitated
by the use of different exercise positions (e.g. side lying),
counter pressure on their perineum, coordination of
contraction/relaxation with breathing. Women are taught
to counterbrace, that is, to pre-contract their pelvic floor
muscles prior to an increase in intra-abdominal pressure
(e.g. coughing, sneezing, lifting), a technique known as
“the knack” [21].
The initial exercise programme is identified and agreed
between the woman and therapist over the first and sec-
ond appointments, according to the woman’s ability.
The exercise programme is practised during subsequent
appointments to allow the therapist to assess progress
and adjust the programme as necessary. Home exercise
may be prescribed from the first appointment, or as
soon as the therapist confirms a correct technique has
been achieved.
Home exercise is tailored to the individual woman, en-
suring a training effect on the muscles is achieved, but
that the programme is manageable for the woman. Tar-
gets of maximum strength, endurance and repetitions
are set, aiming towards a programme of three to five sets
per day of 10 maximum strength pelvic floor muscle
contractions, holding each contraction for up to 10 s
with a 4 s rest between contractions, followed by up to
50 fast contractions. Exercise position is varied (lying,
sitting, standing, squatting). Potential for progression is
determined during the therapy appointments and is car-
ried over to home exercise. Progression is tailored for
each woman [18] and consists of increased number of
contractions, increased length of hold, decreased rest pe-
riods and the introduction of more difficult positions.
Therapists will make use of appropriate motivational
techniques and advice detailed within the protocol to
encourage correct exercise technique and adherence to
Table 2 Outcomes Study site descriptions
Site Urban/rural POPPY experience Current dominant model
1 Urban POPPY recruiting centre Primary and secondary care provision of specialist physiotherapy
referred by primary care and acute services with a mix of 1:1 and
group provision available. Women not routinely sent to physiotherapy
as first line treatment. Several POPPY physiotherapists providing
current input to women with POP
2 Urban Large involvement in medically driven trials
but no focus on physiotherapy based trials
Currently has some specialist physiotherapy involvement but greater
specialist nurse-led service for women
No POPPY involvement
3 Rural No POPPY involvement and limited other
trial involvement
Current interest in re-design and expanding to junior grade
physiotherapists and other nursing staff (as practitioners with
special interest)
4 Urban No POPPY involvement Currently has some specialist physiotherapy involvement, looking
to increase capacity for PFMT provision with other staff groups
5 Urban No POPPY involvement Currently has some specialist physiotherapy involvement, looking
to increase capacity for PFMT provision with other staff groups
PFMT Pelvic Floor Muscle Training, POP Pelvic Organ Prolapse, POPPY Pelvic Organ Prolapse PhysiotherapY trial
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the prescribed programme. Women with urinary and/or
bowel symptoms including urgency, frequency, incontin-
ence and defecation difficulties will be given advice on
to improve these symptoms.
Vaginal examinations will be undertaken following
Chartered Society of Physiotherapy and Royal College of
Obstetrics and Gynaecology guidelines for performing
intimate examinations. Local infection policy will be
adhered to and the woman’s informed consent will be
obtained. A chaperone will be offered. Repeat pelvic
floor muscle assessments will be undertaken at each
session to assess progress and modify home exercises if
the woman is agreeable.
Training to deliver the PFMT intervention
Training will be delivered after Round 2 data collection
has been completed. Clinicians who have been identified
locally through the service planning process will undergo
one full day of bespoke training to prepare them for de-
livering PFMT to women with POP recruited to the
study. This training has been developed specifically for
this study in partnership with the Pelvic, Obstetric and
Gynaecological Physiotherapy (POGP) Group. The train-
ing will be delivered by two POGP trainers per full day
session and one member of the research team. It includes
training in PROPEL specific research processes and paper-
work, an introduction to internal examination, and deliv-
ery of the PFMT programme for women. This training
will ensure that they meet minimum levels of competen-
cies developed in agreement with the POGP. There will
also be ongoing support available locally for staff who have
received this training from specialist women’s health phys-
iotherapists, including observation of initial assessment
and treatment. Any additional support or training re-
quired by staff to deliver the PFMT programme for
women will be recorded (Fig. 1).
Data collection
A) Realist Evaluation
Qualitative data for the RE will be collected in four
rounds at different time-points over an 18 month imple-
mentation period across each site to understand local
contexts and decisions regarding delivery of PFMT for
prolapse and to monitor implementation, up-take, adher-
ence and impact. Error! Reference source not found.
Summarises data to be collected during each round. Two
rounds of data collection will take place during the
planning stages (what to implement and how, and local
theories of change), one round during implementation/
delivery of the models (how is it working) and one round
immediately post implementation (reflection on how it
has worked). All focus groups, interviews and service
planning meetings will be recorded and transcribed.
B) Outcomes study
It is anticipated that each staff member in the five sites
will recruit five women to take part in the study and
who will: agree to complete study outcome questionnaires,
have the POP-Q assessment (pre- and 6 months post) and
take part in qualitative interviews if requested. Patient out-
comes as used in the POPPY trial will be collected at base-
line (immediately prior to first (assessment) appointment)
and at six months and one year follow-up; clinicians will
collect POP-Q data at baseline and 6 months during
specified appointments and the remaining measures
(POP-SS, EQ-5D-5 L, ICIQ-UI SF and patient demo-
graphic data all collated within patient completed ques-
tionnaire) will be collected by post at each time point.
C) Economic Evaluation
Resource use for the PFMT will be collected. Resource
use will be recorded prospectively for every woman
within the study. For the PFMT intervention, cost details
will be gathered from the Intervention Therapists, recorded
at the time of intervention (e.g. length of appointments,
materials used). Data on the use of primary and secondary
care services by the women, including medications, GP
visits and uptake of surgery, will be collected using partici-
pant questionnaires devised by the research team which will
be administered at each of the follow up time periods. Unit
costs/prices for resource use will be obtained using
published estimates for health care services and/or in-
terventions. Costs to the women will be collected in the
participant questionnaires. Data will be collected on the
mode of travel, cost of travel if applicable, amount of
time the women take out of their usual activities such
as work, to go to the appointments and similar data
from family members that either accompany them or
look after their children.
To measure health outcomes, the EQ-5D-5 L generic
instrument will be used [22]. This instrument will pro-
vide the quality of life weights (utility values) to compute
quality adjusted life years (QALYs). Study participants will
complete the EQ-5D-5 L generic instrument within the
questionnaires at baseline and at 6, and 12 months after
randomisation.
Outcome measures
The primary outcome, the Pelvic Organ Prolapse Symptom
Score (POP-SS), will be assessed at baseline, 6 months and
12 months via a self-completed questionnaire. The POP-SS
is a validated tool that includes seven items relating to the
frequency of prolapse symptoms over the previous four
weeks. Each item is scored from 0 (never) to 4 (all of the
time) [23]. This questionnaire booklet will also measure
secondary outcomes, assessing quality of life with the use
of the EQ-5D-5L [24]; urinary incontinence with the ICIQ-
UI short-form [25]; and service related outcomes including
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the need for further treatment. Six and 12 month question-
naires will also address the women’s adherence to the ad-
vice they have been given throughout the intervention (i.e.
avoiding heavy lifting, changes to diet, weight loss) and also
detail any further medical interventions that have been or
are expected to be completed.
POP-Q
Prolapse severity will be assessed as a secondary outcome
with the use of the Pelvic Organ Prolapse Quantification
system (POP-Q) [26]; a standardised and internationally
recognised quantification system for prolapse. It is an
objective, site-specific system for describing, quantifying
and staging pelvic support in women. POP-Q will be per-
formed for each woman in the outcomes study either by a
consultant gynaecologist or a specialist women’s health
physiotherapist trained to perform this assessment.
Data analysis
A) Realist Evaluation
Data from each round will be transcribed verbatim,
organised using the data management software NVivo
version 11, and analysed using a thematic analysis ap-
proach (Ritchie and Spencer [27]). Following familiarisa-
tion with the data by a minimum of two researchers, a
thematic framework will be developed and agreed using
data from a subsample of interview transcripts and the
core concepts of the realist approach – contexts, mecha-
nisms and outcomes. This framework will then be ap-
plied across the dataset through indexing of data
Fig. 1 PROPEL Realist Evaluation and outcomes study flowchart EQ-5D-5 L: EuroQol 5 dimensions questionnaire; ICIQ-UI SF: International Consultation
on Incontinence Questionnaire Urinary Incontinence short form; n: number of participants; PFMT: Pelvic floor muscle training; POP: Pelvic
organ prolapse
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segments. Indexing will be conducted by two researchers
who will cross check a 10% sample of transcripts. Data
will then be tabulated and conceptual maps used to
make links between themes.
Data in each round will be summarised and synthe-
sised across three sites to articulate the context (C) and
mechanisms (M) of action and relate these to observed
(quantitative and qualitative) outcomes (O) – leading to
the development of CMO configurations. Round 1 and 2
data will be used to generate hypotheses about what
potential mechanisms could or would be generated by
the implementation, in what contexts, to achieve what
outcomes. Round 3 data will be used to test these conjec-
tured CMO configurations to understand what mecha-
nisms were actually triggered in practice and how they
were enabled or constricted by certain contexts. Finally,
the hypothesised and observed CMOs will be used to test
if they explain the complex patterning of outcomes of the
PFMT implementation (qualitative and quantitative)
gathered in round 4 and the outcomes study.
B) Outcomes data
Descriptive statistics will be tabulated for all outcomes at
each time point, showing means and SDs for POP − SS
and EQ − 5D-5 L, proportions for POP −Q, the need for
further treatment, and frequencies for the number of NHS
contacts. Differences (and correlations where appropriate)
between baseline and 6 −months and between baseline
and 12 −months will be calculated. We will initially exam-
ine the differences before and after intervention using
paired t-tests and chi-square tests. We will fit appropriate
generalised linear models on the difference between
outcomes before and after intervention, adjusting for
baseline measurements and potential confounders (e.g.
demographic factors, study site). If possible, we will also
explore the effect of different levels of adherence to
PFMT using structural mean models [28]. Complete case
analyses will be performed throughout, with missing data
being addressed in secondary analyses using multiple
imputation methods.
POP − SS and EQ − 5D 5L will be treated as continu-
ous data, POP −Q as ordinal, NHS contacts as count
data and the need for further treatment (e.g. surgery or
pessary) as binary data. In order to facilitate the under-
standing of prolapse related outcomes, individual items
of the POP − SS will also be analysed separately and an
additional dichotomous POP −Q measure (above/below
the hymen) will be included in the analysis.
C) Economic evaluation
Incremental cost-effectiveness ratios (ICERs) will be com-
puted comparing the costs and outcomes of the different
modes of delivery. The difference in effectiveness will be
expressed in terms of the change in POP-SS Score. These
data will be retrieved from the women’s questionnaire re-
sponses to the POP-SS outcome measure. The difference
in utility will be expressed in terms of QALYs. These data
will come from the EQ-5D-5L instrument. Where appro-
priate the analysis of incremental costs, effectiveness and
cost-effectiveness will be based on similar statistical
models as those already outlined (Table 3).
Discussion
This study will enhance knowledge concerning implemen-
tation of the evidence based PFMT protocol in different
NHS settings, potentially using different staff/skill mixes,
intensity of delivery and other innovations to increase ser-
vice capacity. The definitive POPPY trial did not investi-
gate barriers or facilitators to uptake and adoption of
PFMT across varied NHS settings. This study will provide
such knowledge to bridge the ‘implementation gap’. We
have combined a study of implementation alongside a ro-
bust outcomes study, ensuring that we can provide robust
evidence of what works for whom and in what circum-
stances. The patient level outcomes data will also ensure
that we can deliver a robust economic evaluation.
The mixed methods approach being employed in the
PROPEL study will provide valuable data on the feasibil-
ity of delivering this intervention using a number of
models, the resources and environment needed to make
these work and the efficacy of using different clinical
groups than those studied in the POPPY trial.
We have worked in partnership with the POGP to de-
velop bespoke training for a variety of clinicians who
might be identified in different health care settings to
deliver individualised pelvic floor muscle training to
women presenting with stage I, II or III pelvic organ
prolapse. This training has been developed with the
intention of providing clinicians with minimum compe-
tencies in undertaking internal vaginal examinations
and providing appropriate education for clinicians to
provide individualised education and PFMT to women
with POP.
Dissemination and outputs
Two “Dissemination for Implementation” Workshops will
be held: one in England and one in Scotland. These
workshops will bring together clinical leads, service man-
agers, clinicians, professional network organisations (such
as POGP), PPI partners and other key stakeholders, from
the included sites and other NHS Trusts, to hear and
discuss study findings. These events will also ask NHS
service-based participants to discuss the relevance of
findings to their local area and to consider and plan for
local implementation. This can be achieved by taking
on board the knowledge for ‘mechanisms’ of action that
lead to successful implementation, alongside evidence
of what works for who, in what circumstances, and also
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alongside knowledge of longer term outcomes. For ex-
ample, if benefits are maintained then ‘savings’ could
provide a strong argument for investment in PFMT. If
benefits are not maintained then it might be that ‘re-
fresher’ sessions need to be built into future delivery.
These will consist of information sharing but also include
an ‘action planning’ component for service managers
and those responsible for the delivery of non-surgical
interventions for POP to begin to plan for local service
re-design that can deliver PFMT to larger numbers of
women. These events will also act as ‘data gathering’
opportunities for the study, which is why they are in-
cluded as a study objective: gathering data on potential
opposition and barriers to implementation, how services
make sense of and use our study findings and apply these
to their own services. We expect the key people who lead
and manage services for women with POP to attend and
to leave with an action plan.
The findings of the study will also be disseminated
through a number of specialist bodies, responsible for
guiding clinical practice and policy, research priorities,
governance and training of professionals (e.g. the Inter-
national Continence Society (ICS), the Pelvic, Obstetric
and Gynaecological Physiotherapists group (POGP), the
Association for Continence Advice (ACA), the British
Society of Urogynaecologists (BSUG) and the Royal
College of Obstetrics and Gynaecology (RCOG)) and
relevant patient and public involvement organisations
(e.g. Bladder and Bowel UK, CSP website).
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